Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA

Clinical trial NCT02562443 · TERMINATED

Trial details

NCT number: NCT02562443
Sponsor: Traws Pharma, Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Myelodysplastic Syndrome MDS Refractory Anemia With Excess Blasts RAEB

Start date: 2015-12-02
Primary completion: 2020-07-26
Enrollment: 372

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.